Mondego Bio is a new Portuguese startup developing breakthrough cancer treatments. Mondego Bio was founded by these three investors and represents Biovance Capital Fund I’s inaugural investment. LISBON, Portugal, Sept. 18, 2025 /PRNewswire/ — Biovance […]
Honorees demonstrate outstanding clinical work, advocacy, education and community involvement NEW ORLEANS, Sept. 17, 2025 /PRNewswire/ — Representing excellence in the specialty of emergency nursing through clinical practice, research, education and advocacy, the ENA Connection’s 20 […]
–Denifanstat (ASC40) met all primary, key secondary and secondary efficacy endpoints (ITT analysis) and significantly improved moderate-to-severe acne compared with placebo. –Denifanstat (ASC40) demonstrated a favorable safety and tolerability profile. Treatment emergent adverse events (TEAEs) […]
In SURPASS-PEDS, Mounjaro met the primary and all key secondary endpoints at 30 weeks and showed sustained improvement in glycemic control and continued BMI reduction through the study’s 52-week extension The safety and tolerability profile […]
TUALATIN, Ore., Sept. 17, 2025 /PRNewswire/ — SAM Medical, a leading provider of pre-hospital emergency medical products, is pleased to announce the acquisition of TyTek Medical, part of the TyTek Group. TyTek Medical is a […]
